The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition

British Journal of Cancer

Volumn 85, Issue 3, 2001, Pages 446-452

  Webley, S D ^a   Welsh, S J ^a   Jackman, A L ^a   Aherne, G W ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

DUTP; Dutpase; Thymidylate synthase; Uracil misincorporation; ZD9331

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA; PLEVITREXED; PROTEIN P53; THYMIDYLATE SYNTHASE; URACIL DNA GLYCOSYLTRANSFERASE;

ARTICLE; BIOSYNTHESIS; CANCER CELL; CARCINOGENESIS; CELL CYCLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL DIVISION; COLONY-FORMING UNITS ASSAY; DEOXYURACIL NUCLEOTIDES; DNA; DNA DAMAGE; FEMALE; FLOW CYTOMETRY; HUMANS; PYROPHOSPHATASES; QUINAZOLINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMIDYLATE SYNTHASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035800492     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1921     Document Type: Article

References (35)

1. Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition: Effect of Tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse leukaemia cells
2. The role of uracil misincorporation in thymineless death
3. Decreased c-myc protein accompanied by increased p53 and Rb is associated with thymidylate synthase inhibition and cell cycle retardation induced by ZD1694
4. Deoxyuridine triphosphatase (dUTPase) expression and cellular response to TS inhibitors
5. Formation of Okazaki fragments in polyoma DNA synthesis caused by misincorporation of uracil
6. Resistance to fluorodeoxyuridine induced DNA damage and cytotoxicity correlates with an elevation of deoxyuridine triphosphatase activity and failure to accumulate deoxyuridine triphosphate
7. Induction of resistance to fluorodeoxyuridine cytotoxicity and DNA damage in human tumour cells by expression of Escherichia-coli deoxyuridine triphosphatase
8. Uracil DNA-glycosylase: Purification and properties of this enzyme isolated from blast cells of acute myelocytic leukemia patients
9. 5. 10 Dideazatetrahydrofolic acid reduces toxicity and deoyadenosine triphosphate pool expansion in cultural L1210 cells treated with inhihitors of thymidylate synthase
10. Mechanisms of cell death following thymidylate synthase inhibition: 2 deoxyuridine 5 triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole
11. Features of apoptotic cells measured by flow cytometry
12. Bcl-2 modulation of apoptosis induced by anticancer drugs-resistance to thymidylate stress is independent of classical resistance pathways
13. Mechanism of thymineless death
14. Cell cycle control and cancer
15. Cell cycle control processes determine cytostasis or cytotoxicity in thymineless death of colon cancer cells
16. Ratio of 2′-deoxyadenosine-5′triphosphate/thymidine-5′-triphosphate influences the commitment of human colon carcinoma cells to thymineless death
17. The new generation of thymidylate synthase inhibitors in clinical study
18. Cellular pharmacology and invivo activity of a new anticancer agent ZD9331: A water-soluble, nonpolyglutamatable, quinazoline inhibitor of thymidylate synthase
19. Biochemical effects of quinazoline inhibitor of thymidylate synthase CB3717 on human lymphoblastoid cells
20. Principles and practice of DNA filter elution
21. Lowering dUTPase levels through antisense induces sensitivity to fluorodeoxyuridine in HT29 cells
22. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells
23. Specific association of cyclin like uracil-DNA glycosylase with the proliferating cell nuclear antigen
24. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways
25. Mammalian G1 and G2 phase checkpoints
26. Mechanism and pharmacological specificity of dUTPase-mediated protection from DNA damage and cytotoxicity in human tumor cells
27. Generalized blocking in S phase by methotrexate
28. Cell cycle effects of CB30865, a lipophilic quinazoline-based analogue ICI 198583 with an undefined mechanism of action
29. Thymineless apoptotic death induced by 1843U89 in human tumour cell lines is independent of dUTP accumulation and rmsincorporation of dUMP into DNA
30. Dependence of fluorodeoxyuridine-induced cytotoxicity and megabase DNA fragmentation on S phase progression in HT29 cells
31. Purine modulation of methotrexate cytotoxicity in mammalian cell lines
32. Cell cycle effects of antifolate antimetabolites: Implications for cytotoxicity and cytotasis
33. Deoxyuridine triphosphate (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331
34. Time dependence of DNA lesions and growth inhibition by ICI D1694, a new quinazoline antifolate thymidylate synthase inhibitor
35. A comparison of the biological activities of wild type and mutant p53